http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102153589-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_71d3e45bd223a0f315475aeed5669b5a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0f309dc6824143dc072025b96eba1e27
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B2200-07
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B01J2531-827
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B01J2531-007
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B01J2231-643
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B01J2531-0266
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C213-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C231-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C231-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B01J31-2466
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C251-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-657154
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B01J31-186
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D333-36
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C211-45
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D333-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C233-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-6571
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C231-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C209-60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/B01J31-22
filingDate 2011-02-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bb5e667c9935db042c96e85886286122
publicationDate 2011-08-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-102153589-A
titleOfInvention Asymmetric hydrogenation catalyst for imine as well as synthesis method and application thereof
abstract The invention relates to a chiral hydrogenised H8-BINOL dual-phosphine compound the structure of which is shown in the following formula (I), wherein R1 and R2 are halogens, H or C1-C10 fatty groups; R3 is H or C1-C10 fatty groups; R4 is halogen, amino, nitro, H, C1-C10 fatty group or C1-C10 aromatic group; and X is phenyl, substituted phenyl, cyclohexyl, substituted cyclohexyl, a C6-C30 aromatic group, a C6-C30 heteocyclic aromatic group containing one or more of N, S and O. The invention also provides a catalyst which contains the compound and is used for an asymmetric catalytic hydrogenation reaction. By using the catalyst in the imine asymmetric hydrogenation reaction, above 90% of antipodes and more than above 100000 of conversion numbers can be achieved.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112973789-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113244951-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-115417777-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110548546-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110551034-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110551034-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103570484-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113244951-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110551032-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110551032-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109422603-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110551036-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110551036-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112521333-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106467473-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109096137-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112973789-B
priorityDate 2011-02-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID433656902
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425915878
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11052766
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID89929265
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID433595430
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID468321253
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11063239

Total number of triples: 54.